Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trialKathleen N. Moore, Bradley J. Monk, Paul DiSilvestro et al.|The Lancet Oncology|2019Cited by 533
Port-Site Metastasis in Gynecological MalignanciesKelly Benabou, Gulden Menderes, Wafa Khadraoui et al.|JSLS Journal of the Society of Laparoscopic & Robotic Surgeons|2021Cited by 11
Risk‐stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low‐risk endometrial cancerWafa Khadraoui, Gulden Menderes, Christina Tierney et al.|International Journal of Gynecology & Obstetrics|2020Cited by 2
The incidence of microscopic adnexal metastatic disease in women with presumed early stage endometrial cancer.Wafa Khadraoui, Gulden Menderes, Christina Tierney et al.|Journal of Clinical Oncology|2019Cited by 0